These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21577106)

  • 1. New insights into atypical parkinsonism.
    Wenning GK; Krismer F; Poewe W
    Curr Opin Neurol; 2011 Aug; 24(4):331-8. PubMed ID: 21577106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmotor Features in Atypical Parkinsonism.
    Bhatia KP; Stamelou M
    Int Rev Neurobiol; 2017; 134():1285-1301. PubMed ID: 28805573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of parkinsonism.
    Facca AG; Koller WC
    Adv Neurol; 2003; 91():383-96. PubMed ID: 12442697
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G; Fabbrini A; Suppa A
    Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
    Rana AQ; Qureshi AR; Siddiqui O; Sarfraz Z; Rana R; Shtilbans A
    J Neurol; 2019 Sep; 266(9):2093-2102. PubMed ID: 30238268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional trials in atypical parkinsonism.
    Eschlböck S; Krismer F; Wenning GK
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S82-92. PubMed ID: 26421389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing and treating atypical Parkinson disorders.
    Armstrong MJ; McFarland N
    Handb Clin Neurol; 2019; 167():301-320. PubMed ID: 31753139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Application of rTMS in Atypical Parkinsonian Disorders.
    Petsani C; Aloizou AM; Siokas V; Messinis L; Peristeri E; Bakirtzis C; Nasios G; Dardiotis E
    Behav Neurol; 2021; 2021():3419907. PubMed ID: 34976231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the treatment of Parkinson-Plus syndromes.
    Olfati N; Shoeibi A; Litvan I
    Parkinsonism Relat Disord; 2019 Feb; 59():101-110. PubMed ID: 30314846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
    Forrest SL; Crockford DR; Sizemova A; McCann H; Shepherd CE; McGeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; McGinley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM
    Neurology; 2019 May; 92(21):e2472-e2482. PubMed ID: 31019099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.
    Bhidayasiri R; Sringean J; Reich SG; Colosimo C
    Parkinsonism Relat Disord; 2019 Feb; 59():82-92. PubMed ID: 30409560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing disease progression with MRI in atypical parkinsonian disorders.
    Köllensperger M; Wenning GK
    Mov Disord; 2009; 24 Suppl 2():S699-702. PubMed ID: 19877233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.
    Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freezing of gait in postmortem-confirmed atypical parkinsonism.
    Müller J; Seppi K; Stefanova N; Poewe W; Litvan I; Wenning GK
    Mov Disord; 2002 Sep; 17(5):1041-5. PubMed ID: 12360556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
    Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
    Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of falls in postmortem-confirmed parkinsonian disorders.
    Wenning GK; Ebersbach G; Verny M; Chaudhuri KR; Jellinger K; McKee A; Poewe W; Litvan I
    Mov Disord; 1999 Nov; 14(6):947-50. PubMed ID: 10584668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
    Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
    Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.